Literature DB >> 26201616

Hepatic fibrosis developing in morbid obesity independent of steatohepatitis: new mechanism or the Rube Goldberg machine?

Eric R Kallwitz1.   

Abstract

Entities:  

Year:  2012        PMID： 26201616     DOI： 10.1007/s12072-012-9358-3

Source DB:  PubMed          Journal:  Hepatol Int        ISSN： 1936-0533            Impact factor:   6.047


× No keyword cloud information.
  22 in total

Review 1.  Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis.

Authors:  Herbert Tilg; Alexander R Moschen
Journal:  Hepatology       Date:  2010-11       Impact factor: 17.425

Review 2.  Vascular adhesion molecule expression in viral chronic hepatitis: evidence of neoangiogenesis in portal tracts.

Authors:  C García-Monzón; F Sánchez-Madrid; L García-Buey; A García-Arroyo; A García-Sánchez; R Moreno-Otero
Journal:  Gastroenterology       Date:  1995-01       Impact factor: 22.682

3.  Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease.

Authors:  Kerry L Donnelly; Coleman I Smith; Sarah J Schwarzenberg; Jose Jessurun; Mark D Boldt; Elizabeth J Parks
Journal:  J Clin Invest       Date:  2005-05       Impact factor: 14.808

4.  Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings.

Authors:  Elizabeth M Brunt; David E Kleiner; Laura A Wilson; Patricia Belt; Brent A Neuschwander-Tetri
Journal:  Hepatology       Date:  2011-02-11       Impact factor: 17.425

5.  Interleukin-6 induces cellular insulin resistance in hepatocytes.

Authors:  Joseph J Senn; Peter J Klover; Irena A Nowak; Robert A Mooney
Journal:  Diabetes       Date:  2002-12       Impact factor: 9.461

6.  Neovascularization and oxidative stress in the progression of non-alcoholic steatohepatitis.

Authors:  Mitsuteru Kitade; Hitoshi Yoshiji; Hideyuki Kojima; Yasuhide Ikenaka; Ryuichi Noguchi; Kosuke Kaji; Junichi Yoshii; Koji Yanase; Tadashi Namisaki; Masaharu Yamazaki; Tatsuhiro Tsujimoto; Kei Moriya; Hideto Kawaratani; Takemi Akahane; Hiroshi Fukui
Journal:  Mol Med Rep       Date:  2008 Jul-Aug       Impact factor: 2.952

7.  The potential of angiogenesis soluble markers in chronic hepatitis C.

Authors:  Xamila Salcedo; Jesús Medina; Paloma Sanz-Cameno; Luisa García-Buey; Samuel Martín-Vilchez; María J Borque; Manuel López-Cabrera; Ricardo Moreno-Otero
Journal:  Hepatology       Date:  2005-09       Impact factor: 17.425

8.  Visceral fat adipokine secretion is associated with systemic inflammation in obese humans.

Authors:  Luigi Fontana; J Christopher Eagon; Maria E Trujillo; Philipp E Scherer; Samuel Klein
Journal:  Diabetes       Date:  2007-02-07       Impact factor: 9.461

9.  Crosstalk between angiogenesis, cytokeratin-18, and insulin resistance in the progression of non-alcoholic steatohepatitis.

Authors:  Mitsuteru Kitade; Hitoshi Yoshiji; Ryuichi Noguchi; Yasuhide Ikenaka; Kosuke Kaji; Yusaku Shirai; Masaharu Yamazaki; Masahito Uemura; Junichi Yamao; Masao Fujimoto; Akira Mitoro; Masahisa Toyohara; Masayoshi Sawai; Motoyuki Yoshida; Chie Morioka; Tatsuhiro Tsujimoto; Hideto Kawaratani; Hiroshi Fukui
Journal:  World J Gastroenterol       Date:  2009-11-07       Impact factor: 5.742

10.  Proangiogenic cytokines as hypoxia-dependent factors stimulating migration of human hepatic stellate cells.

Authors:  Erica Novo; Stefania Cannito; Elena Zamara; Lorenzo Valfrè di Bonzo; Alessandra Caligiuri; Carlo Cravanzola; Alessandra Compagnone; Sebastiano Colombatto; Fabio Marra; Massimo Pinzani; Maurizio Parola
Journal:  Am J Pathol       Date:  2007-06       Impact factor: 4.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.